Patent · US Active

AMPK activators

US11279702B2 · kind B2 · utility

2Cited by

7References

19Claims

0Family size

Assignee

KALLYOPE, INC. · US

Inventors

Iyassu Sebhat · Jersey City, US
Shuwen He · Fanwood, US

Key dates

Filing date	Oct 15, 2021
Grant date	Mar 22, 2022
Priority date	—
Expiry date	Oct 15, 2041

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P31/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This disclosure is directed, at least in part, to AMPK activators useful for the treatment of conditions or disorders associated with AMPK. In some embodiments, the condition or disorder is associated with the gut-brain axis. In some embodiments, condition or disorder is associated with systemic infection and inflammation from having a leaky gut barrier. In some embodiments, the AMPK activators are gut-restricted compounds. In some embodiments, the AMPK activators are agonists or partial agonists.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.